Cargando…
Arachidonic acid drives adaptive responses to chemotherapy-induced stress in malignant mesothelioma
ABSTRACT: Background High resistance to therapy and poor prognosis characterizes malignant pleural mesothelioma (MPM). In fact, the current lines of treatment, based on platinum and pemetrexed, have limited impact on the survival of MPM patients. Adaptive response to therapy-induced stress involves...
Autores principales: | Cioce, Mario, Canino, Claudia, Pass, Harvey, Blandino, Giovanni, Strano, Sabrina, Fazio, Vito Michele |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8561918/ https://www.ncbi.nlm.nih.gov/pubmed/34727953 http://dx.doi.org/10.1186/s13046-021-02118-y |
Ejemplares similares
-
Insights into Intra-Tumoral Heterogeneity: Transcriptional Profiling of Chemoresistant MPM Cell Subpopulations Reveals Involvement of NFkB and DNA Repair Pathways and Contributes a Prognostic Signature
por: Cioce, Mario, et al.
Publicado: (2021) -
Metformin: Metabolic Rewiring Faces Tumor Heterogeneity
por: Cioce, Mario, et al.
Publicado: (2020) -
Autocrine CSF-1R signaling drives mesothelioma chemoresistance via AKT activation
por: Cioce, M, et al.
Publicado: (2014) -
A STAT3-NFkB/DDIT3/CEBPβ axis modulates ALDH1A3 expression in chemoresistant cell subpopulations
por: Canino, Claudia, et al.
Publicado: (2015) -
Inhibition of the colony-stimulating-factor-1 receptor affects the resistance of lung cancer cells to cisplatin
por: Pass, Harvey I., et al.
Publicado: (2016)